David Clifton’s Post

View profile for David Clifton, graphic

Building world class Life Science teams.

MedTech Mergers & Acquisitions are expected to see a big uptick in 2024 and 2025. Are Johnson & Johnson potentially looking to add to their big-ticket acquisitions in the #Cardiovascular space? This comes off the back of their $16B Abiomed aquisition in late 2022, potentially bolstering their presence in this high value market segment. I'm sure there's lots more exciting changes coming in the coming couple of years. Watch this space. https://lnkd.in/exniAkyz

J&J in talks to buy Shockwave Medical: WSJ

J&J in talks to buy Shockwave Medical: WSJ

medtechdive.com

To view or add a comment, sign in

Explore topics